Anti-SARS-CoV-2S1ProteinRBDCovi-2UC100µg

An antibody reagent directed against the SARS-CoV-2 S1 protein receptor-binding domain (RBD) is offered by STEMCELL Technologies. The Canadian supplier provides specialty cell culture media, cell separation systems, and accessory products, and its catalogue of more than 2,000 cell biology research tools supports scientists working in stem cell, immunology, cancer, regenerative medicine, and cellular therapy research. In Taiwan, the product is available through the exclusive distributor 卓昇有限公司 (02-2736 7100).

STEMCELL Technologies' COVID-19 research resources note that SARS-CoV-2 infects host cells by interacting with the ACE2 receptor on lung epithelial cells. The company's portfolio for studying viral diseases and immune responses includes tools for isolating immune cell subsets, quantifying biomarkers, and supporting monoclonal antibody and cell therapy development workflows.